NEX-I, a biotech developing therapies to overcome resistance to cancer immunotherapy, is seeking a Kosdaq listing, with its ...

MSD Korea is bringing a subcutaneous formulation of its blockbuster cancer drug Keytruda to Korea, offering patients and ...

The number of chronic kidney disease patients in Korea has more than doubled over the past decade, while medical costs more ...

Physical AI could gain an early foothold in urology, where standardized procedures and extensive imaging and surgical video ...

Adults with type 2 diabetes on once-weekly semaglutide injection 1 mg whose dose was increased to 2 mg had a 6 percent lower ...

Korean researchers have identified ETS1 as a key driver of metastasis and immune evasion in head and neck squamous cell ...

Sky Labs and the Korean Society of Hypertension are launching a joint study using about 300,000 real-world cuffless blood ...

Korea may need 12 to 20 proton therapy centers, each capable of treating about 1,000 patients a year, based on estimates of ...

NeoImmuneTech’s U.S. partner Tolerance Bio has added a clinical-stage IL-33 antibody to its thymus-focused pipeline alongside ...

Shares of Ariio Holdings plunged about 18 percent in early trading Wednesday after the company scrapped its planned merger ...

Hanmi Pharmaceutical said on Tuesday that it will regain global rights to its cancer drug belvarafenib after Genentech ...

SK chemicals said Wednesday it received an AAA rating in MSCI's latest environmental, social and governance assessment, up ...